Journal article · 2023 · Open access
INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS
Annals of the Rheumatic Diseases, 1750.2–1751 · Published 30 May 2023 · DOI 10.1136/annrheumdis-2023-eular.6260
In brief
“INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS” is a 2023 journal article by S. Tsiami and 8 co-authors, published in Annals of the Rheumatic Diseases. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Annals of the Rheumatic Diseases.
- Citations
- 0
- Authors
- 9
Abstract
Background In axial spondyloarthritis (axSpA), assessment of disease activity and physical function in clinical studies relies on patient-reported outcomes (PRO) such as patient’s global, BASDAI, ASDAS and BASFI. However, it still remains unclear how response criteria adequately reflects the patients’ opinion on disease status in daily practice. Objectives Investigate whether the results of PROs used in clinical studies with axSpA are indeed related to patient’s opinion on disease status as reported in daily clinical routine. Methods Data were retrieved from the very first and from the last five visits within a timeframe of 5 years. Patient´s clinical characteristics, physician’s global assessment and PROs (ASDAS, BASDAI, BASFI) were assessed at each visit. Status and change of all assessed information during follow-up were compared with patient´s opinion on symptoms related to axSpA, categorized into absent, mild, severe or very severe. Results 3.120 visits with median follow-up (IQR) 4.7 (4.3) years from 557 axSpA patients were analyzed. Absent/mild symptoms were stated in 98.7% and 90.9% of visits with inactive or low ASDAS disease status, while in 67.9% and 39.3% of visits showing association to high or very high ASDAS disease activity status, respectively (Figure 1). In comparison, BASDAI<4 was found in 90.8% of visits with absent/mild symptoms, while BASDAI≥4 showed severe symptoms in 48.1% of visits (Figure 1). Achievement of ASAS40 was associated with 92.4% visits reporting absent/mild symptoms, while this was the case in 76.4% visits despite not reaching ASAS40. Similar data were observed for ASAS20. Severe symptoms were reported in 0.6% patients achieving vs. 30.1% patients not achieving ASAS partial remission (PR). BASFI correlated with patients’ opinion regarding symptoms at each visit. Conclusion Low disease activity as assessed by ASDAS or BASDAI were associated with mild symptoms in the majority of visits over a period of up to 5 years. Interestingly, a large proportion of visits showed low disease activity even when not achieving ASAS20 or ASAS40 responses or ASAS-PR. REFERENCES: NIL. Acknowledgements: NIL. Disclosure of Interests None Declared.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Tsiami, S., Klavdianou, K., Redeker, I., Oezdemir, Y. E., Sewerin, P., KIEFER, D. M., Andreica, I., Kiltz, U., & Baraliakos, X. (2023). INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases, 1750.2–1751. https://doi.org/10.1136/annrheumdis-2023-eular.6260
MLA 9
Tsiami, S., et al. “INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS.” Annals of the Rheumatic Diseases, 2023, pp. 1750.2–1751. https://doi.org/10.1136/annrheumdis-2023-eular.6260.
Chicago
Tsiami, S., Kalliopi Klavdianou, I. Redeker, Yaren Elif Oezdemir, Philipp Sewerin, DAVID M. KIEFER, Ioana Andreica, Uta Kiltz, and Xenofon Baraliakos. 2023. “INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS.” Annals of the Rheumatic Diseases: 1750.2–1751. https://doi.org/10.1136/annrheumdis-2023-eular.6260.
Harvard
Tsiami, S. et al. (2023) ‘INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS’, Annals of the Rheumatic Diseases, pp. 1750.2–1751. doi:10.1136/annrheumdis-2023-eular.6260.
IEEE
S. Tsiami et al., “INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS,” Annals of the Rheumatic Diseases, pp. 1750.2–1751, 2023, doi: 10.1136/annrheumdis-2023-eular.6260.
BibTeX
@article{tsiami2023interpretation,
title = {{INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS}},
author = {Tsiami, S. and Klavdianou, Kalliopi and Redeker, I. and Oezdemir, Yaren Elif and Sewerin, Philipp and KIEFER, DAVID M. and Andreica, Ioana and Kiltz, Uta and Baraliakos, Xenofon},
journal = {Annals of the Rheumatic Diseases},
year = {2023},
pages = {1750.2--1751},
doi = {10.1136/annrheumdis-2023-eular.6260},
url = {https://doi.org/10.1136/annrheumdis-2023-eular.6260}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- axial spondyloarthritis
- patient-reported outcomes
- disease activity
- functional capacity
- quality of life
- ASDAS
- BASDAI
- BASFI
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Tsiami, S., Klavdianou, K., Redeker, I., Oezdemir, Y. E., Sewerin, P., KIEFER, D. M., Andreica, I., Kiltz, U., & Baraliakos, X. (2023). INTERPRETATION OF DISEASE-SPECIFIC QUESTIONNAIRES ON DISEASE ACTIVITY, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN DAILY PRACTICE IN AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases, 1750.2–1751. https://doi.org/10.1136/annrheumdis-2023-eular.6260
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Annals of the Rheumatic Diseases: sign in and open the PDF from this page.
Who wrote this paper?
S. Tsiami, Kalliopi Klavdianou, I. Redeker, Yaren Elif Oezdemir, Philipp Sewerin, DAVID M. KIEFER, Ioana Andreica, Uta Kiltz, Xenofon Baraliakos.
What is the DOI of this paper?
10.1136/annrheumdis-2023-eular.6260, permanently at https://doi.org/10.1136/annrheumdis-2023-eular.6260. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.